February 9, 2024

Now accepting APC Fellow applications

It may seem early, but now is the time to get started on your application for the APC Fellows Program. 

February 9, 2024

APC submits comments on Hawaii, Mississippi bills

This week, APC submitted letters to two state legislatures—a joint letter with NCPA to Hawaii and a letter to Mississippi. 

February 9, 2024

10 timely questions for owners and managers

If you own or manage a compounding pharmacy, here are 10 questions to think about.

February 9, 2024

New year, new guidance: FDA publishes 2024 Guidance Agenda

FDA recently released this year’s CDER Guidance Agenda, a list of new, revised draft, and immediately-in-effect guidance documents it plans to publish this year. There are five listed in the compounding category.

February 2, 2024

Welcome, Tenille!

Pharmacist Tenille Davis officially started in her new role as APC’s chief advocacy officer yesterday.

February 2, 2024

Dear Illinois BOP: Please tell us that’s a typo

APC submitted comments this week to the Illinois Board of Pharmacy regarding its proposed rule on nonresident pharmacies.

February 2, 2024

FDA adds Q&A on medical rationales for animal drug compounding

FDA has added a new section to its Q&A webpage for GFI #256 - Compounding Animal Drugs from Bulk Drug Substances. Here are the high points.

February 2, 2024

Getting what we work for

In life, we might not get what we wish for, but we will definitely get what we work for.

February 2, 2024

New personalized medicine certification in endocrinology

Dr. Pam Smith and the University of South Florida Health Morsani College of Medicine just launched a program designed for pharmacists and focused on a practical approach to BHRT and functional medicine.

January 26, 2024

Calling all owners and managers: You don’t want to miss this.

We’re doing something new for this year’s Owner Summit: Sign up by February 15 and we’ll knock $300 off your registration cost.

January 26, 2024

Musical chairs

This coming week will be like musical chairs at APC, except there’ll be seats enough for us all.

January 26, 2024

Are you throwing away $5,000 a month?

If you haven’t joined APC’s group purchasing deal with Worldpay, you might be throwing away money.

January 26, 2024

APC responds to CVM environmental scan request

APC has submitted responses to an environmental scan request from FDA’s Center for Veterinary Medicine (CVM). This feedback is intended to provide perspective and allow the agency to address weaknesses.

January 19, 2024

Federal judge rules FDA can’t publish unsupported concerns

In a significant ruling this week, a U.S. district judge granted SCA's request and issued a sealed temporary restraining order to block FDA from publishing unsupported concerns about the sterility of the 503B facility.

January 19, 2024

Welcome (and welcome back) to our 2024 Corporate Patrons

This year, we have 36 Corporate Patrons signed on in support of APC, including 22 Tier Corporate Patrons.

January 19, 2024

Forget worms—save $300 with early-bird Owner Summit registration

The professional development event of the year for compounding pharmacy and facility owners and managers is back, and it’s better than ever. 

January 19, 2024

They don’t know what they don’t know

It was another week of interesting reporting on GLP-1s—compounded, counterfeit, and commercially available. APC continues to field multiple media inquiries each week about the GLP-1 craze and compounding’s role in shortages.

January 12, 2024

New tools to educate prescribers on cBHT threat

We’ve got some new tools to help you educate and inform prescribers about the threat to compounded hormone therapy.

January 12, 2024

APC to FDA: Show your work (please?)

APC submitted comments this week on FDA’s Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act.

January 12, 2024

APC leaders talk MOU and more in FDA listening session

In a listening session with representatives from FDA’s Center for Drug Evaluation & Research this week, APC leaders again pressed FDA to support a proposal to eliminate the MOU on interstate shipments of compounded medications.

January 12, 2024

You say goodbye, I say hello …

This week, just two weeks into the new year, in a special-called APC Board of Directors meeting, I resigned as your 2024 APC Board Chair effective January 31. On February 1, I will join the APC staff as Chief Advocacy Officer.

January 5, 2024

Scam Alert: Beware (and be aware).

Pharmacies across the country have been flooded with the fax pictured below. Thing is, it’s a scam.

January 5, 2024

APC submits comments for Senate hearing on drug shortages

On December 5, APC submitted comments to the Senate Finance Committee for a hearing on drug shortages.

January 5, 2024

PCF awards 8 compounding education grants to state associations

The Pharmacy Compounding Foundation has awarded $1,500 compounding education grants to eight state pharmacy associations for 2024.

January 5, 2024

Tell us what didn’t work for you

APC’s fourth annual Owner Summit April 4-6 in LaJolla, Calif., will include a session called “Don’t Bother: Things Not to Try.”

January 5, 2024

We’ve got a story to tell

Happy new year! Thanks to what we achieved in 2023 — especially our membership revenue growth — we’re well positioned to do even more in 2024. 

December 15, 2023

Your unrelenting desire to do right by your patients

As we prepare to celebrate the end of one year and the beginning of another, it seems like a natural time for us all to reflect on what we accomplished in 2023.

December 15, 2023

First pharmacy onboarded with APC credit card processing GPO

Christmas has come early for pharmacy owner Jack Korbutov.

December 15, 2023

Revelation, Empower commit as Diamond-level APC sponsors

Revelation Pharma and Empower have joined Medisca as Diamond-level corporate patrons for 2024.

December 15, 2023

Introducing: New prescriber education tools on cBHT threat

We’ve got some new tools especially designed to help you educate and inform prescribers about the threat to compounded hormone therapy.

« Newer EntriesOlder Entries »